Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+9.26%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$218M
Cap. Flow
% of AUM
0.45%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,105
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$325M |
| 2 |
ConocoPhillips
COP
|
$219M |
| 3 |
Fortive
FTV
|
$205M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$203M |
| 5 |
Devon Energy
DVN
|
$185M |
Top Sells
| 1 |
Royalty Pharma
RPRX
|
$612M |
| 2 |
Exxon Mobil
XOM
|
$353M |
| 3 |
Burlington
BURL
|
$266M |
| 4 |
Dover
DOV
|
$185M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
$175M |
Sector Composition
| 1 | Technology | 20.68% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.04% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
WESCO International
WCC
$10.7B
| $34.4M | 0.07% |
+397,276
| New | +$34.4M |
|
302
Trimble
TRMB
$19.2B
| $34.3M | 0.07% |
+441,458
| New | +$34.3M |
|
303
Paychex
PAYX
$48.7B
| $33.9M | 0.07% |
345,646
-7,200
| -2% | -$706K |
|
304
Cabaletta Bio
CABA
$155M
| $33.8M | 0.07% |
3,041,645
-139,160
| -4% | -$1.54M |
|
305
SBA Communications
SBAC
$21.2B
| $33.7M | 0.07% |
121,500
+97,700
| +411% | +$27.1M |
|
|
BOAC
306
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
| $33.5M | 0.07% |
3,363,526
+2,069,776
| +160% | +$20.6M |
|
307
Timken Company
TKR
$5.42B
| $33.2M | 0.07% |
409,120
+331,177
| +425% | +$26.9M |
|
308
Vinci Compass Investments Ltd. Class A Common Shares
VINP
$642M
| $33.2M | 0.07% |
+2,523,262
| New | +$33.2M |
|
309
Welltower
WELL
$112B
| $33.1M | 0.07% |
462,306
+2,200
| +0.5% | +$158K |
|
310
D.R. Horton
DHI
$54.2B
| $32.7M | 0.07% |
366,775
-2,500
| -0.7% | -$223K |
|
|
AAC
311
DELISTED
Ares Acquisition Corporation
AAC
| $32.7M | 0.07% |
+3,300,000
| New | +$32.7M |
|
|
ANSS
312
DELISTED
Ansys
ANSS
| $32.6M | 0.07% |
96,100
+3,200
| +3% | +$1.09M |
|
313
C4 Therapeutics
CCCC
$194M
| $32.6M | 0.07% |
880,498
-10,000
| -1% | -$370K |
|
314
Williams Companies
WMB
$69.9B
| $32M | 0.07% |
1,349,399
+74,700
| +6% | +$1.77M |
|
315
Bank of New York Mellon
BK
$73.1B
| $31.9M | 0.07% |
675,016
-254,134
| -27% | -$12M |
|
316
XP
XP
$9.96B
| $31.9M | 0.07% |
845,977
-360,228
| -30% | -$13.6M |
|
317
MeiraGTx Holdings
MGTX
$619M
| $31.7M | 0.06% |
2,200,000
+250,000
| +13% | +$3.61M |
|
|
PRPC.U
318
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
| $31.5M | 0.06% |
+3,150,000
| New | +$31.5M |
|
319
DexCom
DXCM
$31.6B
| $31.2M | 0.06% |
347,100
-159,400
| -31% | -$14.3M |
|
320
ProQR Therapeutics
PRQR
$258M
| $31M | 0.06% |
4,694,465
+144,403
| +3% | +$954K |
|
321
Lennar Class A
LEN
$36.7B
| $30.9M | 0.06% |
315,599
-930
| -0.3% | -$91.1K |
|
322
F5
FFIV
$18.1B
| $30.9M | 0.06% |
148,200
-61,300
| -29% | -$12.8M |
|
323
Skyworks Solutions
SWKS
$11.2B
| $30.7M | 0.06% |
167,450
+15,300
| +10% | +$2.81M |
|
|
TCF
324
DELISTED
TCF Financial Corporation Common Stock
TCF
| $30.5M | 0.06% |
656,058
-370,158
| -36% | -$17.2M |
|
325
Gentex
GNTX
$6.25B
| $30.5M | 0.06% |
853,752
-171,456
| -17% | -$6.12M |
|